Search Within

Shyamprasad Deraje Vasudeva

Formats
  1. Journal Article (7)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (12)
  2. Solid Tumor Oncology Division (11)
  3. Head and Neck Service (7)
  4. Department of Pathology and Laboratory Medicine (6)
  5. GSK Faculty (6)
  6. Sarcoma Service (5)

More Groups

People
  1. Gary Schwartz (7)
  2. Alan Ho (5)
  3. William Tap (5)
  4. Elisa De Stanchina (4)
  5. Cristina Antonescu (3)
  6. Ian Ganly (3)

More People

Years
  1. 2018 (2)
  2. 2017 (2)
  3. 2015 (2)
  4. 2014 (2)
  5. 2013 (3)
  6. 2012 (2)

More Years

Publications
  1. Cancer Research (7)
  2. Cancer Cell (1)
  3. Cancer Gene Therapy (1)
  4. Clinical Cancer Research (1)
  5. Journal of Clinical Oncology (1)
  6. Lancet Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Elsevier Science, Inc. (1)
  5. Nature Publishing Group (1)
  6. Public Library of Science (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver
    Meeting Abstract

    Dong, Y.; Ganly, I.; Makarov, V.; Kuo, F.; Deraje, S.; Reznik, E.; Seshan, V.; Nanjangud, G.; Morris, L.; Riaz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes
    Journal Article

    Ganly, I.; Makarov, V.; Deraje, S.; Dong, Y.; Reznik, E.; Seshan, V.; Nanjangud, G.; Eng, S.; Bose, P.; Kuo, F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Genomic alterations in fatal forms of non-anaplastic thyroid cancer: Identification of MED12 and RBM10 as novel thyroid cancer genes associated with tumor virulence
    Journal Article

    Ibrahimpasic, T.; Xu, B.; Landa, I.; Dogan, S.; Middha, S.; Seshan, V.; Deraje, S.; Carlson, D. L.; Migliacci, J.; Knauf, J. A.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Obstruction of BRAF(V600E) transcription by complementary PNA oligomers as a means to inhibit BRAF-mutant melanoma growth
    Journal Article

    Rothman, J. H.; Surriga, O.; de Stanchina, E.; Vasudeva, S. D.; Schwartz, G. K.
    Cancer Gene Therapy (2017)

    Fulltext@MSK | Save
  • Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Ho, A. L.; Foster, N. R.; Meyers, J. P.; Vasudeva, S. D.; Katabi, N.; Antonescu, C. R.; Pfister, D. G.; Horvath, L. E.; Erlichman, C.; Schwartz, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma
    Journal Article

    Slotkin, E. K.; Patwardhan, P. P.; Vasudeva, S. D.; de Stanchina, E.; Tap, W. D.; Schwartz, G. K.
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • Potent antitumor activity of MLN0128, an investigational selective mTORC1/2 kinase inhibitor, in preclinical models of rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E.; Patwardhan, P.; Deraje, S. V. ; Schwartz, G.; Tap, W.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • PNA as novel targeted cancer therapy for BRAF(V600E) mutant melanoma
    Meeting Abstract

    Rothman, J. H.; Surriga, O.; Vasudeva, S. D.; Ambrosini, G.; Ouerfelli, O.; Schwartz, G. K.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • MLN0128, an investigational selective TORC1/2 kinase inhibitor, demonstrates potent antitumor activity in preclinical models of soft tissue sarcoma
    Meeting Abstract

    Patwardhan, P.; Deraje Vasudeva, S.; Tap, W. D.; de Stanchina, E.; Schwartz, G. K.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • KPT-330, a selective small molecule inhibitor of nuclear export, is active in bone and soft tissue sarcoma
    Meeting Abstract

    Nair, J. S.; Tap, W.; Vasudeva, S. D.; Sicklick, J. K.; Kauffman, M.; Shacham, S.; Schwartz, G. K.
    Cancer Research (2013)

    Fulltext@MSK | Save